| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/03/1999 | EP0862553A4 Cbi analogs of cc-1065 and the duocarmycins |
| 02/03/1999 | EP0793649B1 18,19-dinor-vitamin d compounds |
| 02/03/1999 | EP0773938B1 Semi-synthetic taxanes with anti-tumoural activity |
| 02/03/1999 | EP0753000B1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 02/03/1999 | EP0669918B1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| 02/03/1999 | CN1207091A 1-arylsulphonyl, aryl(thio) carbonyl pyridazino derivatives and methods of preparation |
| 02/03/1999 | CN1206598A Tablet medicine for lung cancer and preparation process thereof |
| 02/03/1999 | CN1206597A Xiaojieling and preparation process thereof |
| 02/03/1999 | CN1041929C Heterocyclic derivatives and preparation process and use thereof, medicinal composition containing same |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866702 Purine inhibitors of cyclin dependent kinase 2 |
| 02/02/1999 | US5866699 Oligonucleotides with anti-MDR-1 gene activity |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866692 Process for producing humanized chimera antibody |
| 02/02/1999 | US5866690 Human anti-malignin antibody |
| 02/02/1999 | US5866679 Peptides |
| 02/02/1999 | US5866617 Aqueous solution for administration to patients also receiving cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866615 Lyophilized formulation with anticancer agents; reduced side effects, increased activity |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |
| 02/02/1999 | US5866587 Hydroxamide derivatives of fused piperidine derivatives |
| 02/02/1999 | US5866572 Receptor tyrosine kinase inhibitory properties, treatment of proliferative diseases such as cancer. |
| 02/02/1999 | US5866568 Heterocyclic compounds |
| 02/02/1999 | US5866559 Hormone replacement therapy; endometrioses |
| 02/02/1999 | US5866550 Method of inhibiting replication of hyperproliferative cells using a nucleic acid encoding EIA |
| 02/02/1999 | US5866540 Cyclic adhesion inhibitors |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866329 Method and probe for detection of gene associated with liver neoplastic disease |
| 02/02/1999 | US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors |
| 02/02/1999 | US5866169 Lyophilized formulation with cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866127 Vascular permeability factor targeted compounds |
| 02/02/1999 | US5866124 Antiidiotypic antibodies for high molecular weight-melanoma associated antigen |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 02/02/1999 | CA2017916C Etoposide preparations |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/28/1999 | WO1999004265A2 Cancer associated nucleic acids and polypeptides |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999003995A1 T-cell receptor beta-like protein |
| 01/28/1999 | WO1999003989A1 Human atp-binding cassette transport protein |
| 01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003879A1 Dolastatin 15 derivatives |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003876A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | WO1999003870A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/28/1999 | WO1999003848A1 Thiazole derivatives, method for their production and use |
| 01/28/1999 | WO1999003828A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/28/1999 | WO1999003823A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | WO1999003506A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 01/28/1999 | WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 01/28/1999 | WO1999003498A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 01/28/1999 | WO1999003488A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | WO1998049138A3 Vitamin d3 analogs with bis c-20 side chains |
| 01/28/1999 | WO1998046632A3 Inhibitors for urokinase receptor |
| 01/28/1999 | WO1998038984A3 Formulations for hydrophobic pharmaceutical agents |
| 01/28/1999 | DE19732139A1 Immobilisierung von Vitamin-A-Säure durch kationische Polyelektrolyte Immobilization of vitamin A acid by cationic polyelectrolytes |
| 01/28/1999 | CA2297436A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | CA2297413A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 01/28/1999 | CA2296666A1 T-cell receptor beta-like protein |
| 01/28/1999 | CA2296498A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 01/28/1999 | CA2296447A1 Human atp-binding cassette transport protein |
| 01/28/1999 | CA2296145A1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2294518A1 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0893449A1 Antitumor substance extracted from hen-of-the-woods |
| 01/27/1999 | EP0893121A1 Oral liquid medicine solution |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892801A1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 01/27/1999 | EP0892797A1 Inhibitors of farnesyl protein transferase |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892789A1 Irreversible inhibitors of tyrosine kinases |
| 01/27/1999 | EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1205891A Chinese medicine capsule for curing gastric cancers |
| 01/26/1999 | US5864031 Process for preparing 5-dithio-modified oligonucleotides |
| 01/26/1999 | US5864024 Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis |
| 01/26/1999 | US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain |
| 01/26/1999 | US5864012 Oligopeptides as antitumor agents |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863920 Anticarcinogenic agents and bactericides |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863900 Lhrh antagonists |
| 01/26/1999 | US5863891 Protein fragments joined by peptide bonds |
| 01/26/1999 | US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum |
| 01/26/1999 | US5863797 Gene fusion encoding a hypersecretor protein |
| 01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
| 01/26/1999 | US5863779 UBC7-like ubiquitin-conjugating enzyme |